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Abstract Pretreatment of rat hepatocytes with low-dose nitro- 
gen oxide (addition of SNAP in vitro or induction of nitric oxide 
synthase in vitro or in vivo) imparts resistance to killing and 
decrease in aconitase and mitochondrial electron transfer from 
a second exposure to a higher dose of SNAP. Induction of this 
resistance is prevented by cycloheximide, indicating upregulation 
of protective protein(s). Ferritin levels are increased as are non- 
heme iron-NO EPR signals. Tin-protoporphyrin (SnPP) prevents 
protection, suggesting involvement of hsp32 (heme oxygenase) 
and/or guanylyl cyclase (GC). Cross-resistance to H2Oz killing 
is also observed, which is also prevented by cycloheximide and 
SnPP. Thus, hepatocytes possess inducible protective mecha- 
nisms against nitrogen oxide and reactive oxygen toxicity. 
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1. Introduction 
Nitric oxide is a small, widely diffusible dissolved non-elec- 
trolyte in aqueous olution for which cellular membranes pres- 
ent no appreciable barrier to diffusion [1,2]. In addit ion to its 
functions as a messenger molecule (acting through the heine- 
mediated stimulation of soluble guanylyl cyclase [3]), *NO is 
paramagnet ic  and reacts with metals and with oxygen species 
[4]. There is much data to suggest hat the interaction of • NO 
with oxygen species can affect oxidative injury, although the 
actions of •NO can be to either attenuate or potentiate injury. 
The factors which determine this ' Janus-faced' action of *NO 
[5] are largely unknown. Much of the contradictory data on the 
damaging vs. protective actions of NO synthesis may be due to 
the multiple nitrogen oxide species which are produced in the 
aerobic, chemically complex biological milieu [4] and it is diffi- 
cult to ascribe a particular biological effect to a specific deriva- 
tive of NO. 
We report here that either exogenous (addition of the nitro- 
sothiol S-nitroso-N-acetyl-L-penicil lamine; SNAP) or en- 
dogenous (in vivo or in vitro enzymatic induction) nitrogen 
oxide(s) induces a protective response against an otherwise 
lethal dose of nitrogen oxide(s) in isolated rat hepatocytes. 
Importantly,  this response involves upregulation of protective 
protein(s). We also present data suggesting possible mecha- 
nisms for this protective response. Thus, in addit ion to radical 
reactions which occur during the process of oxidative injury by 
nitrogen and oxygen intermediates, another factor which can 
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dictate the protective vs. damaging actions of nitric oxide pro- 
duction on oxidative injury is the existence of defensive mecha- 
nisms which are upregulated by exposure to these agents. 
2. Experimental 
2.1. Materials' 
Williams media E, Trypan blue, insulin, penicillin, streptomycin, 
L-glutamine and HEPES were purchased from Gibco Laboratories 
(Grand Island, NY). Calf serum was obtained from Hyclone Laborato- 
ries (Logan, UT). Sn-protoporphyrin was purchased from Porphyrin 
Products (Logan). SNAP was synthesized every 2 months as described 
previously [6], stored frozen as a solid aliquot in the dark and checked 
for stoichiometric S-nitrosothiol content by the method of Saville [7]. 
Other chemicals were obtained from Sigma unless otherwise stated. 
2.2. Isolation and treatment of hepatocytes 
Purified hepatocytes were isolated from Sprague-Dawley rats (200 
g) and pretreated with either SNAP (as described in the figure legends) 
or with cytokine mix ('CM') (TNF-~, interferon-~,, interleukin-lfl and 
lipopolysaccharide) + 0.75 mM N~-monomethyl-L-arginine (NMMA) 
[8]. The cells (2.5 ×105 cells/well in 12-well plates) were washed twice 
with media and then treated with media containing 2 mM SNAP for 
12 h. Cell viability was determined after this treatment by Cresyl violet 
staining [9]. In vivo activated hepatocytes were isolated 5 days after 
intraportal injection of rats with killed C. parvum [10]. 
2.3. EPR spectroscopy 
Hepatocytes (1 x 10 7 cells) harvested from culture plates [8] were 
suspended in PBS, transferred toquartz EPR sample tubes and frozen. 
EPR spectra were obtained at 77 K using a Bruker EP-300 spectro- 
photometer. All spectra were time-averaged over 10 scans. Instrumen- 
tal parameters were 3.2 x 105 gain, 1 mW power, 9.44 x 109 Hz micro- 
wave frequency, 6.3 G modulation amplitude, 80 ms time constant and 
20.97 s (x 10 scans) scan time. Signal intensity was calculated from 
height from the baseline of the g = 2.04 excursion. 
2.4. Measurement of ferritin 
For determining the effects of SNAP and SnPP on ferritin levels, 
hepatocytes (5 x 10 6 cells/100 mm plate) pretreated as described in the 
legend to Fig. 4 were washed with ice-cold phosphate buffered saline 
containing 0.1 mM phenylmethylsulfonyl fluoride and lysed by three 
cycles of freezing and thawing. Cytosolic fraction was obtained from 
the supernatant of a 12000 rpm 15 min centrifuge (microcentrifuge) at 
4°C. Quantitative ferritin determination was performed by ELISA 
using polyclonal antibody (Sigma A5762) of horse spleen ferritin and 
anti-rabbit IgG (Sigma A3687) conjugated with alkaline phosphatase 
with the standard curve of rat liver ferritin (Sigma P7005) following 
previously published procedures [11]. Protein concentration was meas- 
ured by protein assay kit (p5656, Sigma). 
2.5. Aconitase assays and respiration measurements 
Samples for mitochondrial conitase assay were prepared and as- 
sayed as described by Drapier and Hibbs [12]. Aconitase activity was 
measured spectrophotometrically t 240 nm by disappearance of cis- 
aconitate. The reaction was started with the addition of 0.2 mM cis- 
aconitate and enzyme activity was determined from the initial reaction 
rate using an extinction coefficient of 3.4 cm -~ mM -a at 240 nm [13] for 
cis-aconitate. Oxygen consumption was measured using a Clark type 
electrode (YSI Instruments). Hepatocytes were permeabilized with 
0.0075% digitonin in respiration medium (250 mM sucrose, 2 mM 
HEPES, 2.5 mM KHzPO 4, 210 mM mannitol and 0.5 mM EDTA). 
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Effective permeabilization was determined by Trypan blue staining. 
Measurement of mitochondrial respiration was initiated by adding per- 
meabilized hepatocytes into respiration medium supplemented with 
1 mM ADP and 10 mM fl-hydroxybutyrate, 2.5mM MgC12 and 0.7% 
BSA and appropriate substrate/inhibitor as described [14]. 
3. Results 
For the data in Fig. l, hepatocytes with or without various 
pretreatments were subjected to a 12-h incubation i  medium 
with NMMA alone (solid bars) or 0.75 mM NMMA + 2 mM 
SNAP (open bars) and viability determined as described in 
section 2. As shown in 1A, compared with previously untreated 
hepatocytes ('CTRL'), cells which had previously produced 
o NO by induction with cytokine mix ('CM') or pretreated 
with low (100/zM) SNAP are virtually completely resistant to 
killing. The effect of CM pretreatment is due to oNO produc- 
tion, since it is prevented by the presence of NMMA during 
CM pretreatment ('CM + NMMA'). SNAP effects (both pro- 
tection and killing) are due to SNAP-induced nitrogen oxide 
formation, since the same concentration of the parent com- 
pound not containing the thionitrite moiety (NAP) has no ef- 
fect (see below). In addition, pretreatment with media which 
had SNAP added 12 h prior does not induce protection (data 
not shown). 
In contrast o hepatocytes i olated from normal animals, 
preinjection with C. parvum 5 days prior to isolation and 16 h 
preculture are resistant to the toxic effect of SNAP treatment 
(1B). C. parvum treatment has been shown previously to induce 
a major hepatic inflammatory response, including prodigious 
• NO synthesis both in vivo and by hepatocytes isolated from 
the animals [15]. Interestingly, prevention o f -NO synthesis by 
the hepatocytes during the 16-h culture prior to SNAP addition 
( 'NMMA' pretreatment) does not render the cells sensitive, 
indicating that a protective response induced in vivo by 
C. parvum injection carries over during subsequent culture. 
Alternatively, the small amount of • NO synthesis in the pres- 
ence of NMMA may be enough to induce the resistance. 
For Fig. 2, SNAP killing was measured for hepatocytes pre- 
treated with the indicated SNAP concentrations for 14 h (2A) 
or pretreatment with 100 J~M SNAP for the indicated times 
(2B). Maximal protection is induced with 5(~100/~M SNAP 
concentration (2A) and requires 8-12 h to develop (2B, 
squares)). Pretreatment alone, with no subsequent SNAP expo- 
sure (2B, circles) results in no toxicity. 
Two critical intracellular targets for the toxic effects of nitric 
oxide formation are the iron-containing enzymatic activities 
aconitase and mitochondrial e ectron transfer (most especially 
complexes I and II) [16], including the isolated rat hepatocyte 
[17]. Fig. 3 shows the effects of SNAP pre- and posttreatment 
on these activities. Hepatocytes were pre- and posttreated as 
described in Fig. 1, except that the duration of the second 
SNAP treatment was 4 h instead of 12 h. During this abbrevi- 
ated time there was insignificant cell lysis (not shown), but 
significant decrease in activities of aconitase and upstream seg- 
ments of mitochondrial electron transfer. As shown in Fig. 3A, 
pretreatment with low-level SNAP results in substantial protec- 
tion against subsequent high-level SNAP-induced ecrease in 
aconitase activity. Interestingly, SNAP pretreatment, alone, ap- 
pears to induce an approximately 30% increase in aconitase 
activity, perhaps via upregulation of internal iron homeostatic 
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Fig. 1. High concentration SNAP-mediated cytotoxicity toward (A) 
hepatocytes pretreated invitro with either CM + NMMA or with low 
concentration SNAP and (B) hepatocytes from C. parvum-treated rats. 
(A) Normal hepatocytes were precultured for 20 h with either no addi- 
tion ('CTRL'), CM, CM + 0.75 mM NMMA or with 100/IM SNAP 
for 14 h. These cultures were then exposed to NMMA alone (solid bars) 
or NMMA + 2 mM SNAP (open bars) for 12 h and cell viability was 
determined as described in section 2. (B) Hepatocytes isolated from 
C. parvum-treated rats (5 days) were precultured in the absence 
('CTRL') or presence ('NMMA') of 0.75 mM NMMA for 16 h, then 
exposed for 12 h to NMMA alone (solid bars) or NMMA+2 mM 
SNAP (open bars) and viability was determined asdescribed above. 
regulatory mechanisms [18,19]. A similar protective ffect is 
observed on inhibition of mitochondrial electron transfer 
through complexes I+ I I I+ IV  and I I+ I I I+ IV  (3B). There is 
no effect of SNAP on Complex IV activity. As is also true for 
cytotoxicity (Fig. 2B), pretreatment alone ('SNAP/None') re- 
sults in no appreciable decrease in activity. 
We have shown recently that one effect of endogenous • NO 
synthesis n isolated rat hepatocytes is upregulation of the heat 
shock protein hsp32, heme oxygenase (HO), as a result of 
nitrogen oxide-induced liberation of enzyme-bound (primarily 
cytochrome P450) heme [20,21]. We were thus interested to 
know whether HO may play a role in SNAP-induced induction 
of an autoprotective response. As shown in Fig. 3A, tin-proto- 
porphyrin IX ('SnPP'), which is a potent inhibitor of HO [22], 
indeed prevents the protective ffects of low-SNAP pretreat- 
ment on subsequent high-SNAP inhibition of aconitase activity 
('SNAP+SnPP'). SnPP alone does not alter the sensitivity of 
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Table 1 
Effects of various pretreatments on high concentration SNAP and 
H202 cytotoxicity and on intensity of EPR-detectable dithioldinitrosyl 
iron complex EPR signal (g = 2.04) 
Addition Addition Viability g = 2.04 Signal 
during during (%) (arb. U/mg) 
Pretreatment Postreatment 
None None 100- UD 
None SNAP 51.8 + 4.9 0.20 + 0.01 
SNAP None 102.1 + 6.3 UD 
SNAP SNAP 87.4 _+ 5.2 0.32 + 0.01" 
NAP SNAP 54.2 + 5.2 0.22 + 0.01 
SNAP + CHX SNAP 49.0 + 7.4 0.19 + 0.02 
CHX SNAP 45.0 + 6.0 0.18 + 0.01 
SNAP + SnPP SNAP 51.3 + 5.8 0.22 + 0.01 
SnPP SNAP 48.0 + 3.9 0.19 + 0.04 
None H202 44.5 + 4.7 ND 
SNAP H202 80.1 + 6.4 ND 
NAP H202 46.7 + 3.2 ND 
SNAP + CHX H202 39.6 + 4.4 ND 
CHX H202 37.9 + 6.2 ND 
SNAP + SnPP H202 40.6 + 4.0 ND 
SnPP H202 43.6 + 2.7 ND 
Hepatocytes were incubated with the indicated pretreatments for 14 h. 
For viability measurements, posttreatment with or without SNAP (2 
mM) was for 12 h and with or without H202 (5 mM) was for 3 h. The 
EPR measurements were performed in cells harvested after 4 h 
posttreatment. Details are described in section 2. UD, undetectable; 
ND, not determined. *P 0.002 vs. none/SNAP. 
non-pretreated cells to h igh-SNAP ('SnPP').  Protection against 
loss of mitochondrial  electron transfer activities is also pre- 
vented by SnPP, which also has no effect alone (3B). It is 
important  to point out, however, that SnPP also inhibits soluble 
guanylyl cyclase [23] (which potently responds to • NO in hepa- 
tocytes, increasing cGMP [15,24]) and so based on this data 
alone the protective effect of low-SNAP pretreatment could 
also be due to cGMP elevation. 
We also examined the results of these and other treatments 
on the appearance of the 'g = 2.04' electron paramagnetic reso- 
nance (EPR) signal in hepatocytes (Table 1), indicative of the 

















Fig. 2. Dose (A) and time (B) response of low concentrations of SNAP 
pretreatment on subsequent high concentration SNAP-induced cyto- 
toxicity. (A) Dose response of the indicated increasing SNAP concen- 
trations (14 h preexposure) on subsequent cytotoxicity of 12 h treat- 
ment with 2 mM SNAR Viability was determined as described in 
section 2. (B) Time course of the development of resistance toward 
2 mM SNAP; hepatocytes were pretreated with 100/,tM SNAP for the 
indicated times and then washed and incubated 12 h without (circles) 
or with (squares) 2 mM SNAP. Viability was determined as described 
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Fig. 3. Effect of low concentration SNAP pretreatment on subsequent 
high-concentration SNAP-induced inhibition of mitochondrial coni- 
tase activity (A) and mitochondrial respiration (B). Hepatocytes were 
pretreated 14 h as described in section 2without or with 100/~M SNAP, 
25 ,uM and then posttreated without or with 2 mM SNAP for 4 h. 
Mitochondrial aconitase and respiration were measured as described 
in section 2. 
[10,25,26]. As we expected, no addit ion during the pretreatment 
followed by high-level (2 mM) SNAP for 12 h results in signif- 
icant decrease in viability and also the appearance, after 4 h, 
of this signal. Pretreatment with SNAP alone (no SNAP during 
the second incubation) does not alter viability and the g -- 2.04 
signal was undetectable. However, concomitant with substan- 
tial protection against killing the pretreatment also significantly 
increases the intensity of the EPR signal from DNIC.  Pretreat- 
ment with the parent compound (NAP) results in no resistance 
to SNAP- induced viability nor  increase in the intensity of the 
g = 2.04 signal, again demonstrat ing that the resistance induc- 
tive effect is due to nitrogen oxide formation from SNAP. 
Addit ion of the translational inhibitor cycloheximide (CHX, 10 
¢tg/ml) prevents the low SNAP- induced protection and in- 
creased DNIC  formation. This effect is not due to increased 
non-specific toxicity from CHX alone, since there is no increase 
in toxicity or effect on the g -- 2.04 signal when CHX is present 
during the preincubation without SNAP. This result, along 
with the relatively slow time frame of the resistance induction 
effect (Fig. 2B), indicates that this effect involves an increase 
in expression of protective protein(s). The autoinductive pro- 
tective effect of low-level SNAP against toxicity and also in- 
crease in the g =- 2.04 signal are abrogated by SnPP. As with 
CHX, the effect of SnPP is not due to increased non-specific 
toxicity. As also shown in Table 1, pretreatment with low-level 
SNAP induces protection against oxidative toxicity from H202, 
which is not exhibited by the parent compound and prevented 
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Fig. 4. Effect of SNAP (100 pM) without or with SnPP (25 ,uM) on 
hepatocyte f rritin levels. Cells were treated with SNAP and at various 
times intracellular ferritin levels were determined as described in sec- 
tion 2. 
by CHX and by SnPP. This indicates that nitrogen oxide expo- 
sure induces resistance to injury from both reactive nitrogen 
and reactive oxygen species. 
We have previously shown that endogenous or exogenous 
nitrogen oxide exposure induces modest but significant increase 
in cytosolic non-heme iron [20,21]. Increased cytosolic iron is 
known to upregulate the synthesis of ferritin, which may be an 
important protective response against oxidative injury by se- 
questering iron and thus preventing the formation of hydroxyl 
radical via the Fenton reaction [27]. As shown in Fig. 4, com- 
pared with control hepatocytes treatment with 100 ¢tM SNAP 
induces increased (N 3-fold) ferritin expression over a time frame 
similar to the induction of resistance (Fig. 2) and this increase 
is prevented by SnPP. Interestingly, in the presence of SnPP the 
levels of ferritin decrease substantially, perhaps indicative of 
nitrogen oxide-mediated downregulation of ferritin expression 
via activation of the iron-responsive element mechanism, as 
documented previously [18,19]. This result suggests that in 
hepatocytes iron liberation from heme by the action of heme 
oxygenase indeed upregulates ferritin expression. 
4. Discussion 
We have shown previously that *NO upregulates hsp32 
(heme oxygenase-1; HO-1) via liberation of intracellular heme 
[20] and suggested that this may be a protective response [21]. 
Welsh and Sandler have shown induction of H•  mRNA and 
protection against *NO toxicity by addition of heme [28], al- 
though exogenous heme addition could protect by directly 
scavenging •NO. HO-1 has been shown to be upregulated 
under conditions of oxidative stress [29] and may also be in- 
volved in the •NO-induced protective response observed here 
since addition of the inhibitor SnPP abrogates the installation 
of resistance by • NO pretreatment. The mechanism of protec- 
tion could involve the production of billirubin (a potent antiox- 
idant [30]) after enzymatic reduction of billiverdin, a product 
of HO-1 activity. In addition, we show here that low-dose •NO 
upregulates ferritin, which could be due to iron release from 
HO-mediated heme breakdown [20]. Ferritin has been pro- 
posed to be protective against oxidative stress by sequestering 
'loosely bound' iron which may otherwise participate in hy- 
droxyl radical formation via the Fenton reaction [27,31]. 
It is also possible that • NO-induced increased cellular cGMP 
levels may increase protection (through unknown mecha- 
nisms), since SnPP is also an inhibitor of soluble guanylyl 
cyclase [23]. In addition to *NO, GC activity is also stimulated 
by oxidants and based on this effect such a protective role for 
cGMP has been hypothesized previously [32]. It is also possible 
that *NO-induced heme loss increases cGMP levels since both 
heme [33] and CO (a product of H•  activity) [34] stimulate GC 
activity. There is also evidence that exposure of hem•proteins 
to reactive oxygen species is capable of inducing heine libera- 
tion, which could also result in HO-1 increase [35,36]. However, 
although it has been shown that •NO-cGMP effects can be 
protective against ischemia/reperfusion [37] and all•graft sur- 
vival posttransplant [38] through increased vasodilatation and 
decreased thrombosis, we know of no reports of a role for 
cGMP in protection against cellular oxidative injury in vitro. 
In addition to decreased cytotoxicity, low-SNAP pretreat- 
ment decreases the degree of inhibition of mitochondrial e ec- 
tron transfer caused by high-SNAP treatment and also in- 
creases the intensity of the EPR signal from cellular DNIC. We 
have shown a similar increase in DNIC formation in cells ex- 
pressing increased levels of metallothionein which also induces 
resistance to SNAP toxicity and DNA damage [39], although 
mitochondrial function was not measured. However, at present 
we do not know the identity of the thiol ligands in the DNIC 
and whether these complexes play a causal role in protection. 
It is worth noting in this regard that Kuo and Slivka have 
shown that endogenously produced 'NO is capable of modula- 
tion of intracellular glutathione l vels in hepatocytes suggesting 
the possibility that the changes in the intensity of the DNIC 
signal may reflect changes in thiol levels [40]. The lesser amount 
of mitochondrial ctivity loss by low-SNAP pretreatment could 
be due to several factors, including increased scavenging of 
• NO (perhaps reflected by the increased DNIC signal) 
and/or increased recovery/repair of activity [17,41]. 
Finally, we emphasize that all these treatments were per- 
formed aerobically, which means that the effects (both induc- 
tion of resistance and cellular damage) may be due to multiple 
reactive nitrogen oxide species in addition to • NO [42]. Protec- 
tion may involve a general response to oxidative injury, which 
could explain the cross-resistance imparted to H202 toxicity. 
Also, although SNAP can spontaneously iberate .NO the 
mechanism of this liberation is complex, involving metal ions 
[43], oxygen [44] or cellular metabolism [45]. As an S-nitroso- 
thiol, some of the actions of SNAP could also be due to transni- 
trosation (transfer of nitrosonium, NO+), as has been suggested 
previously for several important actions of •NO [46]. 
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